Enhancement of plasminogen activator activity stimulated by LPS in gingival fibroblasts of individuals with Down syndrome.
Individuals with Down syndrome (DS) have a high prevalence of periodontal disease, which develops early and progressed rapidly and extensively, in comparison with healthy controls. The severe periodontal disease in individuals with DS has been considered to result from abnormal factors in their host responses. The mechanisms involved in the periodontal inflammatory processes in individuals with DS are not fully understood. Plasminogen activators (PA) are serine proteases that are well known for their part in the initiation of the fibrinolytic cascade leading to the generation of plasmin in periodontal homeostasis, including fibrinolysis and connective tissue remodeling. The PA-plasmin system affects the progression of periodontal disease. In the present study, we examined the effects of the levels of PA activity stimulated with lipopolysaccharide (LPS) in the gingival fibroblasts from donors with DS (DGF). The levels of PA activity without LPS were low in the DGFs, the same as that in the gingival fibroblasts from donors of healthy controls (NDGF). In contrast, the levels of PA activity with LPS in DGFs were significantly higher than that in the NDGFs. These results suggested that PA plays an important role in inducing extensive and rapid inflammation in the periodontal disease in individuals with DS.
Otsuka
Y
Y
Department of Dentistry for the Disabled, Nihon University School of Dentistry at Matsudo, Chiba, Japan. ykboo@mascat.nihon-u.ac.jp
Ito
M
M
Yamaguchi
M
M
Uesu
K
K
Uehara
S
S
Kasai
K
K
Abiko
Y
Y
Mega
J
J
D000293:Adolescent; D000328:Adult; D016976:Aggregatibacter actinomycetemcomitans / Q000737:chemistry; D000704:Analysis of Variance; D016022:Case-Control Studies; D004305:Dose-Response Relationship, Drug; D004314:Down Syndrome / Q000150:complications* / Q000503:physiopathology; D005347:Fibroblasts / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008070:Lipopolysaccharides / Q000494:pharmacology*; D010518:Periodontitis / Q000209:etiology* / Q000503:physiopathology; D010960:Plasminogen Activators / Q000502:physiology*; D015203:Reproducibility of Results; D018709:Statistics, Nonparametric
D008070:Lipopolysaccharides; D010960:Plasminogen Activators